| Authors: |
Savina M; Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux cedex 33076, France.; INSERM CIC-EC 14.01 (Clinical Epidemiology), Bordeaux 33000, France.; INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Center, Epicene Team, Bordeaux 33000, France.; University of Bordeaux, ISPED, Centre INSER M U1219 Bordeaux Population Health, Epicene Team, Bordeaux 33000, France., Litière S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels 1200, Belgium., Italiano A; Medical Oncology Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux cedex 33076, France., Burzykowski T; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), Hasselt University, Hasselt 3500, Belgium., Bonnetain F; Methodology and Quality of life in Oncology Unit, Besançon EA3181, France., Gourgou S; Biometrics Unit, Institut du Cancer de Montpellier, Univ. Montpellier, Montpellier 34298, France., Rondeau V; INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Center, Epicene Team, Bordeaux 33000, France.; INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Center, Biostatistic Team, Bordeaux 33000, France., Blay JY; Centre Léon Bérard, Comprehensive Cancer Center, Lyon 69008, France.; University Claude Bernard Lyon I, Lyon 69000, France., Cousin S; Medical Oncology Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux cedex 33076, France., Duffaud F; Medical Oncology Unit, University Hospital La Timone and University of Aix-Marseille, Marseille 13005, France., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden 2300RC, The Netherlands., Gronchi A; Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Judson I; Institute of Cancer Research, Sutton, Surrey, United Kingdom., Le Cesne A; Medicine Department, Institut Gustave Roussy, Comprehensive Cancer Center, Villejuif 94800, France., Lorigan P; University of Manchester and Christie NHS Foundation Trust, Manchester M20 4BX, UK., Maurel J; Department of Medical Oncology, Hospital Clinic, CIBERehd, Translational Genomics and Targeted Therapeutics in Solid Tumors (IDIBAPS), Barcelona 08036, Spain., van der Graaf W; The Institute of Cancer Research, Sutton, London SM2 5NG, United Kingdom.; Radboud University Medical Centre, Department of Medical Oncology, GA Nijmegen 6525, The Netherlands.; Royal Marsden NHS Foundation Trust, Chelsea, London, United Kingdom., Verweij J; Department of Medical Oncology, Erasmus University Medical Center, CE Rotterdam 3015, The Netherlands., Mathoulin-Pélissier S; Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux cedex 33076, France.; INSERM CIC-EC 14.01 (Clinical Epidemiology), Bordeaux 33000, France.; INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Center, Epicene Team, Bordeaux 33000, France.; University of Bordeaux, ISPED, Centre INSER M U1219 Bordeaux Population Health, Epicene Team, Bordeaux 33000, France., Bellera C; Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux cedex 33076, France.; INSERM CIC-EC 14.01 (Clinical Epidemiology), Bordeaux 33000, France.; INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Center, Epicene Team, Bordeaux 33000, France.; University of Bordeaux, ISPED, Centre INSER M U1219 Bordeaux Population Health, Epicene Team, Bordeaux 33000, France. |
